Edition:
United Kingdom

Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

3.84USD
23 May 2018
Change (% chg)

$-0.02 (-0.52%)
Prev Close
$3.86
Open
$3.86
Day's High
$3.87
Day's Low
$3.75
Volume
9,827
Avg. Vol
56,332
52-wk High
$5.72
52-wk Low
$0.43

Chart for

About

Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $28.92
Shares Outstanding(Mil.): 26.05
Dividend: --
Yield (%): --

Financials

  CERC.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -1.21 -- --
ROI: -210.84 1.57 14.38
ROE: -265.70 2.43 16.07

BRIEF-Cerecor Q4 Loss Per Share $0.11

* REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017

02 Apr 2018

BRIEF-Cerecor Inc Appoints Peter Greenleaf CEO

* CERECOR APPOINTS PETER GREENLEAF AS CHIEF EXECUTIVE OFFICER

28 Mar 2018

BRIEF-Cerecor To Acquire Avadel Pharmaceuticals' Pediatric Assets

* CERECOR TO ACQUIRE AVADEL PHARMACEUTICALS' PEDIATRIC ASSETS

12 Feb 2018

Earnings vs. Estimates